Zelenskiy says White House did not inform him of documents leak, Washington Post reports

(Reuters) – Ukrainian President Volodymyr Zelenskiy told the Washington Post in an interview published on Tuesday that the White House did not inform him about a leak of secret U.S. documents that grabbed attention around the world last month. “I did not receive information from the White House or the Pentagon beforehand,” Zelenskiy was quoted…

Read More

Russia’s war on Ukraine latest: General says Ukraine won’t give up on Bakhmut

(Reuters) – The Ukrainian general in charge of ground forces said his troops would not give up the eastern city of Bakhmut as they prepare to begin a counteroffensive against occupying Russian forces. FIGHTING/MILITARY * The United States plans to announce as soon as Wednesday a $300 million military aid package for Ukraine that will…

Read More
PNC Says It Can Offer Up To $15 Billion In Short-term Debt To Provide Additional Liquidity

PNC Says It Can Offer Up To $15 Billion In Short-term Debt To Provide Additional Liquidity

(Please read headline “to provide additional liquidity” instead of “ease liquidity worries” and in first paragraph please read “to provide additional liquidity” instead of “to calm investor worries”) (Reuters) -PNC Financial Services Group Inc said on Tuesday the parent company and its banking unit can offer up to $15 billion of its commercial paper to…

Read More

Vanda Pharmaceuticals sues U.S. government over drug trade secrets

By Blake Brittain (Reuters) – Vanda Pharmaceuticals Inc has sued the federal government in Washington, D.C., federal court over accusations that the U.S. Food and Drug Administration passed trade secrets about its schizophrenia drug Fanapt and sleep-disorder medication Hetlioz to generic competitors. In a complaint made public Tuesday, Vanda said the agency disclosed confidential details…

Read More

Amgen sues Novartis to block generic osteoporosis, bone cancer drugs

By Blake Brittain (Reuters) – Amgen Inc sued Novartis AG’s Sandoz in New Jersey federal court Monday, accusing Sandoz’s proposed versions of its multibillion-dollar bone-strengthening drugs Prolia and Xgeva of infringing several patents. Amgen asked the court to block Sandoz’s biosimilars of the drugs until its patents expire. One of the patents named in the…

Read More

Clorox rethinks strategy on Kingsford charcoal ahead of summer grilling season

By Jessica DiNapoli NEW YORK (Reuters) – Clorox Co is revamping its sales plans for its Kingsford grilling briquettes and pellets, staples at summer barbecues across the United States, after hiking prices and losing market share to competitors, an executive told Reuters on Tuesday. The Oakland, California-based company bumped up prices on Kingsford charcoal in…

Read More